For the past four years, I have been insisting that our problem is not about salary increments but about being a productive ...

Discover how Innate Pharma's patent on KIR3DL2-targeting agents revolutionizes CTCL treatment. Learn about specific doses and frequencies for optimal results in T cell malignancy therapy.

Verastem stock dips 70% due to updated clinical data, but trading opportunity may arise with FDA's rolling submission ...

Rishi Sunak might not like it, but next month's General Election is as much a vote on the past 14 years of Tory rule as it is ...

Those victims who raised a voice of dissent were hacked down. The herders were emboldened in their bloody campaign by the loud silence of the indolent government, which turned a blind eye to their ...